Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market Growth 2026-2032
The global Human Immunoglobulin For Intramuscular Injection (IMIG) market size is predicted to grow from US$ 982 million in 2025 to US$ 1622 million in 2032; it is expected to grow at a CAGR of 7.6% from 2026 to 2032.
Human immunoglobulin for intramuscular injection (IMIG), commonly known as "IMIG", is an immunoglobulin preparation extracted and purified from healthy human plasma. It contains a variety of antibodies and is mainly used to enhance immunity. It is used by intramuscular injection and cannot be infused intravenously. Its functions include: 1. Prevention of infection: By providing antibodies against viruses (such as measles, hepatitis A, rubella, etc.) and bacteria, it helps prevent infections caused by these pathogens. 2. Replacement of xenogeneic blood products: Avoid the immune response caused by the use of animal blood products (such as horses, mice, etc.) to improve safety. 3. Treatment of immunodeficiency: Provide supplements for patients who cannot produce enough immunoglobulins on their own to help improve the function of the immune system.
United States market for Human Immunoglobulin For Intramuscular Injection (IMIG) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Human Immunoglobulin For Intramuscular Injection (IMIG) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Human Immunoglobulin For Intramuscular Injection (IMIG) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Human Immunoglobulin For Intramuscular Injection (IMIG) players cover Grifols, Pfizer, Octapharma, Takeda, Kedrion Biopharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
This Insight Report provides a comprehensive analysis of the global Human Immunoglobulin For Intramuscular Injection (IMIG) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Immunoglobulin For Intramuscular Injection (IMIG) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Immunoglobulin For Intramuscular Injection (IMIG) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Immunoglobulin For Intramuscular Injection (IMIG) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Immunoglobulin For Intramuscular Injection (IMIG).
This report presents a comprehensive overview, market shares, and growth opportunities of Human Immunoglobulin For Intramuscular Injection (IMIG) market by product type, application, key manufacturers and key regions and countries.
Human immunoglobulin for intramuscular injection (IMIG), commonly known as "IMIG", is an immunoglobulin preparation extracted and purified from healthy human plasma. It contains a variety of antibodies and is mainly used to enhance immunity. It is used by intramuscular injection and cannot be infused intravenously. Its functions include: 1. Prevention of infection: By providing antibodies against viruses (such as measles, hepatitis A, rubella, etc.) and bacteria, it helps prevent infections caused by these pathogens. 2. Replacement of xenogeneic blood products: Avoid the immune response caused by the use of animal blood products (such as horses, mice, etc.) to improve safety. 3. Treatment of immunodeficiency: Provide supplements for patients who cannot produce enough immunoglobulins on their own to help improve the function of the immune system.
United States market for Human Immunoglobulin For Intramuscular Injection (IMIG) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Human Immunoglobulin For Intramuscular Injection (IMIG) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Human Immunoglobulin For Intramuscular Injection (IMIG) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Human Immunoglobulin For Intramuscular Injection (IMIG) players cover Grifols, Pfizer, Octapharma, Takeda, Kedrion Biopharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Human Immunoglobulin For Intramuscular Injection (IMIG) Industry Forecast” looks at past sales and reviews total world Human Immunoglobulin For Intramuscular Injection (IMIG) sales in 2025, providing a comprehensive analysis by region and market sector of projected Human Immunoglobulin For Intramuscular Injection (IMIG) sales for 2026 through 2032. With Human Immunoglobulin For Intramuscular Injection (IMIG) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Immunoglobulin For Intramuscular Injection (IMIG) industry.This Insight Report provides a comprehensive analysis of the global Human Immunoglobulin For Intramuscular Injection (IMIG) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Immunoglobulin For Intramuscular Injection (IMIG) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Immunoglobulin For Intramuscular Injection (IMIG) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Immunoglobulin For Intramuscular Injection (IMIG) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Immunoglobulin For Intramuscular Injection (IMIG).
This report presents a comprehensive overview, market shares, and growth opportunities of Human Immunoglobulin For Intramuscular Injection (IMIG) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Children
- Adult
Segmentation by Application:
- Disease Prevention
- Treatment
- Diagnosis
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Grifols
- Pfizer
- Octapharma
- Takeda
- Kedrion Biopharma
- CSL Behring
- Tiantan Biological
- Hualan Biological
- Henjiu
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Human Immunoglobulin For Intramuscular Injection (IMIG) market?
- What factors are driving Human Immunoglobulin For Intramuscular Injection (IMIG) market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Human Immunoglobulin For Intramuscular Injection (IMIG) market opportunities vary by end market size?
- How does Human Immunoglobulin For Intramuscular Injection (IMIG) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Human Immunoglobulin For Intramuscular Injection (IMIG) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Human Immunoglobulin For Intramuscular Injection (IMIG) by Country/Region, 2021, 2025 & 2032
2.2 Human Immunoglobulin For Intramuscular Injection (IMIG) Segment by Type
2.2.1 Children
2.2.2 Adult
2.2.3 Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type
2.2.3.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Type (2021-2026)
2.2.3.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sale Price by Type (2021-2026)
2.3 Human Immunoglobulin For Intramuscular Injection (IMIG) Segment by Application
2.3.1 Disease Prevention
2.3.2 Treatment
2.3.3 Diagnosis
2.3.4 Other
2.3.5 Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application
2.3.5.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sale Market Share by Application (2021-2026)
2.3.5.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Breakdown Data by Company
3.1.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Annual Sales by Company (2021-2026)
3.1.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Company (2021-2026)
3.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Annual Revenue by Company (2021-2026)
3.2.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Company (2021-2026)
3.2.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Company (2021-2026)
3.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sale Price by Company
3.4 Key Manufacturers Human Immunoglobulin For Intramuscular Injection (IMIG) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Immunoglobulin For Intramuscular Injection (IMIG) Product Location Distribution
3.4.2 Players Human Immunoglobulin For Intramuscular Injection (IMIG) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMAN IMMUNOGLOBULIN FOR INTRAMUSCULAR INJECTION (IMIG) BY GEOGRAPHIC REGION
4.1 World Historic Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Geographic Region (2021-2026)
4.1.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Country/Region (2021-2026)
4.2.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Growth
4.4 APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Growth
4.5 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Growth
4.6 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Growth
5 AMERICAS
5.1 Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country
5.1.1 Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021-2026)
5.1.2 Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Country (2021-2026)
5.2 Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2026)
5.3 Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Region
6.1.1 APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Region (2021-2026)
6.1.2 APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Region (2021-2026)
6.2 APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2026)
6.3 APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) by Country
7.1.1 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021-2026)
7.1.2 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Country (2021-2026)
7.2 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2026)
7.3 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) by Country
8.1.1 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Country (2021-2026)
8.2 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2026)
8.3 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Immunoglobulin For Intramuscular Injection (IMIG)
10.3 Manufacturing Process Analysis of Human Immunoglobulin For Intramuscular Injection (IMIG)
10.4 Industry Chain Structure of Human Immunoglobulin For Intramuscular Injection (IMIG)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Immunoglobulin For Intramuscular Injection (IMIG) Distributors
11.3 Human Immunoglobulin For Intramuscular Injection (IMIG) Customer
12 WORLD FORECAST REVIEW FOR HUMAN IMMUNOGLOBULIN FOR INTRAMUSCULAR INJECTION (IMIG) BY GEOGRAPHIC REGION
12.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size Forecast by Region
12.1.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Forecast by Region (2027-2032)
12.1.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Forecast by Type (2027-2032)
12.7 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Grifols
13.1.1 Grifols Company Information
13.1.2 Grifols Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
13.1.3 Grifols Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Grifols Main Business Overview
13.1.5 Grifols Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
13.2.3 Pfizer Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Octapharma
13.3.1 Octapharma Company Information
13.3.2 Octapharma Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
13.3.3 Octapharma Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Octapharma Main Business Overview
13.3.5 Octapharma Latest Developments
13.4 Takeda
13.4.1 Takeda Company Information
13.4.2 Takeda Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
13.4.3 Takeda Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Takeda Main Business Overview
13.4.5 Takeda Latest Developments
13.5 Kedrion Biopharma
13.5.1 Kedrion Biopharma Company Information
13.5.2 Kedrion Biopharma Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
13.5.3 Kedrion Biopharma Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Kedrion Biopharma Main Business Overview
13.5.5 Kedrion Biopharma Latest Developments
13.6 CSL Behring
13.6.1 CSL Behring Company Information
13.6.2 CSL Behring Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
13.6.3 CSL Behring Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 CSL Behring Main Business Overview
13.6.5 CSL Behring Latest Developments
13.7 Tiantan Biological
13.7.1 Tiantan Biological Company Information
13.7.2 Tiantan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
13.7.3 Tiantan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Tiantan Biological Main Business Overview
13.7.5 Tiantan Biological Latest Developments
13.8 Hualan Biological
13.8.1 Hualan Biological Company Information
13.8.2 Hualan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
13.8.3 Hualan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Hualan Biological Main Business Overview
13.8.5 Hualan Biological Latest Developments
13.9 Henjiu
13.9.1 Henjiu Company Information
13.9.2 Henjiu Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
13.9.3 Henjiu Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Henjiu Main Business Overview
13.9.5 Henjiu Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Human Immunoglobulin For Intramuscular Injection (IMIG) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Human Immunoglobulin For Intramuscular Injection (IMIG) by Country/Region, 2021, 2025 & 2032
2.2 Human Immunoglobulin For Intramuscular Injection (IMIG) Segment by Type
2.2.1 Children
2.2.2 Adult
2.2.3 Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type
2.2.3.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Type (2021-2026)
2.2.3.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sale Price by Type (2021-2026)
2.3 Human Immunoglobulin For Intramuscular Injection (IMIG) Segment by Application
2.3.1 Disease Prevention
2.3.2 Treatment
2.3.3 Diagnosis
2.3.4 Other
2.3.5 Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application
2.3.5.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sale Market Share by Application (2021-2026)
2.3.5.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Breakdown Data by Company
3.1.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Annual Sales by Company (2021-2026)
3.1.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Company (2021-2026)
3.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Annual Revenue by Company (2021-2026)
3.2.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Company (2021-2026)
3.2.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Company (2021-2026)
3.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sale Price by Company
3.4 Key Manufacturers Human Immunoglobulin For Intramuscular Injection (IMIG) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Immunoglobulin For Intramuscular Injection (IMIG) Product Location Distribution
3.4.2 Players Human Immunoglobulin For Intramuscular Injection (IMIG) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMAN IMMUNOGLOBULIN FOR INTRAMUSCULAR INJECTION (IMIG) BY GEOGRAPHIC REGION
4.1 World Historic Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Geographic Region (2021-2026)
4.1.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Country/Region (2021-2026)
4.2.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Growth
4.4 APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Growth
4.5 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Growth
4.6 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Growth
5 AMERICAS
5.1 Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country
5.1.1 Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021-2026)
5.1.2 Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Country (2021-2026)
5.2 Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2026)
5.3 Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Region
6.1.1 APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Region (2021-2026)
6.1.2 APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Region (2021-2026)
6.2 APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2026)
6.3 APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) by Country
7.1.1 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021-2026)
7.1.2 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Country (2021-2026)
7.2 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2026)
7.3 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) by Country
8.1.1 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Country (2021-2026)
8.2 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2026)
8.3 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Immunoglobulin For Intramuscular Injection (IMIG)
10.3 Manufacturing Process Analysis of Human Immunoglobulin For Intramuscular Injection (IMIG)
10.4 Industry Chain Structure of Human Immunoglobulin For Intramuscular Injection (IMIG)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Immunoglobulin For Intramuscular Injection (IMIG) Distributors
11.3 Human Immunoglobulin For Intramuscular Injection (IMIG) Customer
12 WORLD FORECAST REVIEW FOR HUMAN IMMUNOGLOBULIN FOR INTRAMUSCULAR INJECTION (IMIG) BY GEOGRAPHIC REGION
12.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size Forecast by Region
12.1.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Forecast by Region (2027-2032)
12.1.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Forecast by Type (2027-2032)
12.7 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Grifols
13.1.1 Grifols Company Information
13.1.2 Grifols Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
13.1.3 Grifols Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Grifols Main Business Overview
13.1.5 Grifols Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
13.2.3 Pfizer Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Octapharma
13.3.1 Octapharma Company Information
13.3.2 Octapharma Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
13.3.3 Octapharma Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Octapharma Main Business Overview
13.3.5 Octapharma Latest Developments
13.4 Takeda
13.4.1 Takeda Company Information
13.4.2 Takeda Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
13.4.3 Takeda Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Takeda Main Business Overview
13.4.5 Takeda Latest Developments
13.5 Kedrion Biopharma
13.5.1 Kedrion Biopharma Company Information
13.5.2 Kedrion Biopharma Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
13.5.3 Kedrion Biopharma Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Kedrion Biopharma Main Business Overview
13.5.5 Kedrion Biopharma Latest Developments
13.6 CSL Behring
13.6.1 CSL Behring Company Information
13.6.2 CSL Behring Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
13.6.3 CSL Behring Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 CSL Behring Main Business Overview
13.6.5 CSL Behring Latest Developments
13.7 Tiantan Biological
13.7.1 Tiantan Biological Company Information
13.7.2 Tiantan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
13.7.3 Tiantan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Tiantan Biological Main Business Overview
13.7.5 Tiantan Biological Latest Developments
13.8 Hualan Biological
13.8.1 Hualan Biological Company Information
13.8.2 Hualan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
13.8.3 Hualan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Hualan Biological Main Business Overview
13.8.5 Hualan Biological Latest Developments
13.9 Henjiu
13.9.1 Henjiu Company Information
13.9.2 Henjiu Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
13.9.3 Henjiu Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Henjiu Main Business Overview
13.9.5 Henjiu Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Human Immunoglobulin For Intramuscular Injection (IMIG) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Human Immunoglobulin For Intramuscular Injection (IMIG) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Children
Table 4. Major Players of Adult
Table 5. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2026) & (K Dose)
Table 6. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Type (2021-2026)
Table 7. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type (2021-2026) & ($ million)
Table 8. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Type (2021-2026)
Table 9. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sale Price by Type (2021-2026) & (US$/Dose)
Table 10. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sale by Application (2021-2026) & (K Dose)
Table 11. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sale Market Share by Application (2021-2026)
Table 12. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Application (2021-2026) & ($ million)
Table 13. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Application (2021-2026)
Table 14. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sale Price by Application (2021-2026) & (US$/Dose)
Table 15. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Company (2021-2026) & (K Dose)
Table 16. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Company (2021-2026)
Table 17. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Company (2021-2026)
Table 19. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sale Price by Company (2021-2026) & (US$/Dose)
Table 20. Key Manufacturers Human Immunoglobulin For Intramuscular Injection (IMIG) Producing Area Distribution and Sales Area
Table 21. Players Human Immunoglobulin For Intramuscular Injection (IMIG) Products Offered
Table 22. Human Immunoglobulin For Intramuscular Injection (IMIG) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Geographic Region (2021-2026) & (K Dose)
Table 26. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share Geographic Region (2021-2026)
Table 27. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country/Region (2021-2026) & (K Dose)
Table 30. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Country/Region (2021-2026)
Table 31. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021-2026) & (K Dose)
Table 34. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Country (2021-2026)
Table 35. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2026) & (K Dose)
Table 37. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2026) & (K Dose)
Table 38. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Region (2021-2026) & (K Dose)
Table 39. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Region (2021-2026)
Table 40. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2026) & (K Dose)
Table 42. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2026) & (K Dose)
Table 43. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021-2026) & (K Dose)
Table 44. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2026) & (K Dose)
Table 46. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2026) & (K Dose)
Table 47. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021-2026) & (K Dose)
Table 48. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2026) & (K Dose)
Table 50. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2026) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of Human Immunoglobulin For Intramuscular Injection (IMIG)
Table 52. Key Market Challenges & Risks of Human Immunoglobulin For Intramuscular Injection (IMIG)
Table 53. Key Industry Trends of Human Immunoglobulin For Intramuscular Injection (IMIG)
Table 54. Human Immunoglobulin For Intramuscular Injection (IMIG) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Human Immunoglobulin For Intramuscular Injection (IMIG) Distributors List
Table 57. Human Immunoglobulin For Intramuscular Injection (IMIG) Customer List
Table 58. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Forecast by Region (2027-2032) & (K Dose)
Table 59. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Forecast by Country (2027-2032) & (K Dose)
Table 61. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Forecast by Region (2027-2032) & (K Dose)
Table 63. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Forecast by Country (2027-2032) & (K Dose)
Table 65. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Forecast by Country (2027-2032) & (K Dose)
Table 67. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Forecast by Type (2027-2032) & (K Dose)
Table 69. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Forecast by Application (2027-2032) & (K Dose)
Table 71. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Grifols Basic Information, Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturing Base, Sales Area and Its Competitors
Table 73. Grifols Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
Table 74. Grifols Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 75. Grifols Main Business
Table 76. Grifols Latest Developments
Table 77. Pfizer Basic Information, Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturing Base, Sales Area and Its Competitors
Table 78. Pfizer Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
Table 79. Pfizer Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 80. Pfizer Main Business
Table 81. Pfizer Latest Developments
Table 82. Octapharma Basic Information, Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturing Base, Sales Area and Its Competitors
Table 83. Octapharma Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
Table 84. Octapharma Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 85. Octapharma Main Business
Table 86. Octapharma Latest Developments
Table 87. Takeda Basic Information, Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturing Base, Sales Area and Its Competitors
Table 88. Takeda Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
Table 89. Takeda Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 90. Takeda Main Business
Table 91. Takeda Latest Developments
Table 92. Kedrion Biopharma Basic Information, Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturing Base, Sales Area and Its Competitors
Table 93. Kedrion Biopharma Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
Table 94. Kedrion Biopharma Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 95. Kedrion Biopharma Main Business
Table 96. Kedrion Biopharma Latest Developments
Table 97. CSL Behring Basic Information, Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturing Base, Sales Area and Its Competitors
Table 98. CSL Behring Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
Table 99. CSL Behring Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 100. CSL Behring Main Business
Table 101. CSL Behring Latest Developments
Table 102. Tiantan Biological Basic Information, Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturing Base, Sales Area and Its Competitors
Table 103. Tiantan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
Table 104. Tiantan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 105. Tiantan Biological Main Business
Table 106. Tiantan Biological Latest Developments
Table 107. Hualan Biological Basic Information, Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturing Base, Sales Area and Its Competitors
Table 108. Hualan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
Table 109. Hualan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 110. Hualan Biological Main Business
Table 111. Hualan Biological Latest Developments
Table 112. Henjiu Basic Information, Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturing Base, Sales Area and Its Competitors
Table 113. Henjiu Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
Table 114. Henjiu Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 115. Henjiu Main Business
Table 116. Henjiu Latest Developments
Table 1. Human Immunoglobulin For Intramuscular Injection (IMIG) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Human Immunoglobulin For Intramuscular Injection (IMIG) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Children
Table 4. Major Players of Adult
Table 5. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2026) & (K Dose)
Table 6. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Type (2021-2026)
Table 7. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type (2021-2026) & ($ million)
Table 8. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Type (2021-2026)
Table 9. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sale Price by Type (2021-2026) & (US$/Dose)
Table 10. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sale by Application (2021-2026) & (K Dose)
Table 11. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sale Market Share by Application (2021-2026)
Table 12. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Application (2021-2026) & ($ million)
Table 13. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Application (2021-2026)
Table 14. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sale Price by Application (2021-2026) & (US$/Dose)
Table 15. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Company (2021-2026) & (K Dose)
Table 16. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Company (2021-2026)
Table 17. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Company (2021-2026)
Table 19. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sale Price by Company (2021-2026) & (US$/Dose)
Table 20. Key Manufacturers Human Immunoglobulin For Intramuscular Injection (IMIG) Producing Area Distribution and Sales Area
Table 21. Players Human Immunoglobulin For Intramuscular Injection (IMIG) Products Offered
Table 22. Human Immunoglobulin For Intramuscular Injection (IMIG) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Geographic Region (2021-2026) & (K Dose)
Table 26. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share Geographic Region (2021-2026)
Table 27. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country/Region (2021-2026) & (K Dose)
Table 30. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Country/Region (2021-2026)
Table 31. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021-2026) & (K Dose)
Table 34. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Country (2021-2026)
Table 35. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2026) & (K Dose)
Table 37. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2026) & (K Dose)
Table 38. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Region (2021-2026) & (K Dose)
Table 39. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Region (2021-2026)
Table 40. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2026) & (K Dose)
Table 42. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2026) & (K Dose)
Table 43. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021-2026) & (K Dose)
Table 44. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2026) & (K Dose)
Table 46. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2026) & (K Dose)
Table 47. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021-2026) & (K Dose)
Table 48. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2026) & (K Dose)
Table 50. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2026) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of Human Immunoglobulin For Intramuscular Injection (IMIG)
Table 52. Key Market Challenges & Risks of Human Immunoglobulin For Intramuscular Injection (IMIG)
Table 53. Key Industry Trends of Human Immunoglobulin For Intramuscular Injection (IMIG)
Table 54. Human Immunoglobulin For Intramuscular Injection (IMIG) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Human Immunoglobulin For Intramuscular Injection (IMIG) Distributors List
Table 57. Human Immunoglobulin For Intramuscular Injection (IMIG) Customer List
Table 58. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Forecast by Region (2027-2032) & (K Dose)
Table 59. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Forecast by Country (2027-2032) & (K Dose)
Table 61. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Forecast by Region (2027-2032) & (K Dose)
Table 63. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Forecast by Country (2027-2032) & (K Dose)
Table 65. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Forecast by Country (2027-2032) & (K Dose)
Table 67. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Forecast by Type (2027-2032) & (K Dose)
Table 69. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Forecast by Application (2027-2032) & (K Dose)
Table 71. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Grifols Basic Information, Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturing Base, Sales Area and Its Competitors
Table 73. Grifols Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
Table 74. Grifols Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 75. Grifols Main Business
Table 76. Grifols Latest Developments
Table 77. Pfizer Basic Information, Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturing Base, Sales Area and Its Competitors
Table 78. Pfizer Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
Table 79. Pfizer Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 80. Pfizer Main Business
Table 81. Pfizer Latest Developments
Table 82. Octapharma Basic Information, Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturing Base, Sales Area and Its Competitors
Table 83. Octapharma Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
Table 84. Octapharma Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 85. Octapharma Main Business
Table 86. Octapharma Latest Developments
Table 87. Takeda Basic Information, Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturing Base, Sales Area and Its Competitors
Table 88. Takeda Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
Table 89. Takeda Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 90. Takeda Main Business
Table 91. Takeda Latest Developments
Table 92. Kedrion Biopharma Basic Information, Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturing Base, Sales Area and Its Competitors
Table 93. Kedrion Biopharma Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
Table 94. Kedrion Biopharma Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 95. Kedrion Biopharma Main Business
Table 96. Kedrion Biopharma Latest Developments
Table 97. CSL Behring Basic Information, Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturing Base, Sales Area and Its Competitors
Table 98. CSL Behring Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
Table 99. CSL Behring Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 100. CSL Behring Main Business
Table 101. CSL Behring Latest Developments
Table 102. Tiantan Biological Basic Information, Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturing Base, Sales Area and Its Competitors
Table 103. Tiantan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
Table 104. Tiantan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 105. Tiantan Biological Main Business
Table 106. Tiantan Biological Latest Developments
Table 107. Hualan Biological Basic Information, Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturing Base, Sales Area and Its Competitors
Table 108. Hualan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
Table 109. Hualan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 110. Hualan Biological Main Business
Table 111. Hualan Biological Latest Developments
Table 112. Henjiu Basic Information, Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturing Base, Sales Area and Its Competitors
Table 113. Henjiu Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolios and Specifications
Table 114. Henjiu Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 115. Henjiu Main Business
Table 116. Henjiu Latest Developments
LIST OF FIGURES
Figure 1. Picture of Human Immunoglobulin For Intramuscular Injection (IMIG)
Figure 2. Human Immunoglobulin For Intramuscular Injection (IMIG) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Country/Region (2025)
Figure 10. Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Children
Figure 12. Product Picture of Adult
Figure 13. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Type in 2026
Figure 14. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Type (2021-2026)
Figure 15. Human Immunoglobulin For Intramuscular Injection (IMIG) Consumed in Disease Prevention
Figure 16. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market: Disease Prevention (2021-2026) & (K Dose)
Figure 17. Human Immunoglobulin For Intramuscular Injection (IMIG) Consumed in Treatment
Figure 18. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market: Treatment (2021-2026) & (K Dose)
Figure 19. Human Immunoglobulin For Intramuscular Injection (IMIG) Consumed in Diagnosis
Figure 20. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market: Diagnosis (2021-2026) & (K Dose)
Figure 21. Human Immunoglobulin For Intramuscular Injection (IMIG) Consumed in Other
Figure 22. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market: Other (2021-2026) & (K Dose)
Figure 23. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sale Market Share by Application (2025)
Figure 24. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Application in 2026
Figure 25. Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Company in 2026 (K Dose)
Figure 26. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Company in 2026
Figure 27. Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Company in 2026 ($ millions)
Figure 28. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Company in 2026
Figure 29. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales 2021-2026 (K Dose)
Figure 32. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue 2021-2026 ($ millions)
Figure 33. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales 2021-2026 (K Dose)
Figure 34. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue 2021-2026 ($ millions)
Figure 35. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales 2021-2026 (K Dose)
Figure 36. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales 2021-2026 (K Dose)
Figure 38. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue 2021-2026 ($ millions)
Figure 39. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Country in 2026
Figure 40. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Country (2021-2026)
Figure 41. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Type (2021-2026)
Figure 42. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Application (2021-2026)
Figure 43. United States Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Region in 2026
Figure 48. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Region (2021-2026)
Figure 49. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Type (2021-2026)
Figure 50. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Application (2021-2026)
Figure 51. China Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 55. India Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Country in 2026
Figure 59. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Country (2021-2026)
Figure 60. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Type (2021-2026)
Figure 61. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Application (2021-2026)
Figure 62. Germany Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 63. France Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Application (2021-2026)
Figure 70. Egypt Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Human Immunoglobulin For Intramuscular Injection (IMIG) in 2026
Figure 76. Manufacturing Process Analysis of Human Immunoglobulin For Intramuscular Injection (IMIG)
Figure 77. Industry Chain Structure of Human Immunoglobulin For Intramuscular Injection (IMIG)
Figure 78. Channels of Distribution
Figure 79. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Forecast by Region (2027-2032)
Figure 80. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Human Immunoglobulin For Intramuscular Injection (IMIG)
Figure 2. Human Immunoglobulin For Intramuscular Injection (IMIG) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Country/Region (2025)
Figure 10. Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Children
Figure 12. Product Picture of Adult
Figure 13. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Type in 2026
Figure 14. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Type (2021-2026)
Figure 15. Human Immunoglobulin For Intramuscular Injection (IMIG) Consumed in Disease Prevention
Figure 16. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market: Disease Prevention (2021-2026) & (K Dose)
Figure 17. Human Immunoglobulin For Intramuscular Injection (IMIG) Consumed in Treatment
Figure 18. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market: Treatment (2021-2026) & (K Dose)
Figure 19. Human Immunoglobulin For Intramuscular Injection (IMIG) Consumed in Diagnosis
Figure 20. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market: Diagnosis (2021-2026) & (K Dose)
Figure 21. Human Immunoglobulin For Intramuscular Injection (IMIG) Consumed in Other
Figure 22. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market: Other (2021-2026) & (K Dose)
Figure 23. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sale Market Share by Application (2025)
Figure 24. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Application in 2026
Figure 25. Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Company in 2026 (K Dose)
Figure 26. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Company in 2026
Figure 27. Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Company in 2026 ($ millions)
Figure 28. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Company in 2026
Figure 29. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales 2021-2026 (K Dose)
Figure 32. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue 2021-2026 ($ millions)
Figure 33. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales 2021-2026 (K Dose)
Figure 34. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue 2021-2026 ($ millions)
Figure 35. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales 2021-2026 (K Dose)
Figure 36. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales 2021-2026 (K Dose)
Figure 38. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue 2021-2026 ($ millions)
Figure 39. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Country in 2026
Figure 40. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Country (2021-2026)
Figure 41. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Type (2021-2026)
Figure 42. Americas Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Application (2021-2026)
Figure 43. United States Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Region in 2026
Figure 48. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Region (2021-2026)
Figure 49. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Type (2021-2026)
Figure 50. APAC Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Application (2021-2026)
Figure 51. China Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 55. India Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Country in 2026
Figure 59. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Country (2021-2026)
Figure 60. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Type (2021-2026)
Figure 61. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Application (2021-2026)
Figure 62. Germany Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 63. France Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Application (2021-2026)
Figure 70. Egypt Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Human Immunoglobulin For Intramuscular Injection (IMIG) in 2026
Figure 76. Manufacturing Process Analysis of Human Immunoglobulin For Intramuscular Injection (IMIG)
Figure 77. Industry Chain Structure of Human Immunoglobulin For Intramuscular Injection (IMIG)
Figure 78. Channels of Distribution
Figure 79. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Forecast by Region (2027-2032)
Figure 80. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share Forecast by Application (2027-2032)
